ondasdechoque.org
PT-BR

Lateral elbow tendinopathy · Randomized trial · 2024

How did radial shockwave compare with exercise or advice for tennis elbow?

In this small trial of 60 people with tennis elbow, all three groups improved. After three radial shockwave sessions, the elbow pain-and-function score fell from about 44 to about 18 out of 100 by 3 months. The exercise and advice groups also improved, to about 26 and 24.

Improved over time in all groups
adults with tennis elbow
60
shockwave sessions, about a week apart
3
months of follow-up
6

Good to know: A small pilot trial to plan a larger study. Everyone attended all their shockwave sessions.

Sveinall H, Brox JI, Engebretsen KB, et al. BMJ Open, 2024 · Read the paper ↗

How this study worked

Shockwave +advice20 peopleExercise +advice20 peopleAdvice alone20 people
People were assigned to the groups by lot. Each dot is one person.

Conceptual animation: a radial wave spreads from the applicator and weakens with distance. Not to scale. Tap the field to send a pulse.

What happened

Tennis elbow pain and function

PRTEE score, 0–100 · lower means fewer symptoms

Shockwave + adviceExercise + adviceAdvice alone

All three groups started at about 43 to 49 and improved. By 6 months, scores were about 15 with shockwave, 20 with exercise and 14 with advice alone.
Show the numbers
GroupStart3 months6 months
Shockwave + advice43.818.115.3
Exercise + advice4325.720.5
Advice alone48.623.913.7

The treatment

Shockwave + advice

Radial, once a week for 3 weeks

Radial wavesSpread out from the skin; strongest near the surface
Sessions
3, one a week
Pulses
2,000 per session
Strength
1.5–3bar · 10 per second
Numbing
Not mentioned
Device
EMS-DolorClast, Swiss DolorClast Evo blue handpiece
Everyone also got
Information and advice on gradually loading the arm

Compared with: Heavy slow resistance exercise at home for 12 weeks, or information and advice alone

Settings are what each study used, not a prescription.

Who took part

60 adults (average age about 48, 68% women) with tennis elbow in Norwegian hospital care, 20 in each group.

Shockwave + advice20 people
Exercise + advice20 people
Advice alone20 people

Side effects

Two people had more pain for up to 12 hours after shockwave. In the exercise group, five reported more pain from training.

All the numbers and the full appraisal

Every reported result

FROM THE FULL PAPER

The results, in numbers.

60 adults with tennis elbow randomized 20 per arm in Norwegian secondary care; mean age 47.8 (SD 9.3), 68% women. Feasibility sample, not effectiveness cohort.

Radial ESWT20randomized

Twenty randomized per arm. Follow-up completion varied; arm-specific analyzed denominator is stated per outcome when reported.

Heavy-slow resistance training20randomized

Twenty randomized per arm. Follow-up completion varied; arm-specific analyzed denominator is stated per outcome when reported.

Information and advice20randomized

Twenty randomized per arm. Follow-up completion varied; arm-specific analyzed denominator is stated per outcome when reported.

Trial feasibility and progression criteria1 reported outcome
01
Recruitment through 6-month follow-up

Trial feasibility and progression criteria

Counts, percentages and prespecified process thresholds

Eligibility (78%), willingness to be randomised (92%) and ESWT attendance (100%) met their targets, but the recruitment rate (3.37 per month) was below the 3.75 target; 6-month retention was 68%, below the >75% criterion. Training compliance was low: 6/19 (32%) achieved at least 30 of 36 sessions. Authors conclude amendments are needed before a full trial.

Analysis details and source

Table 2 exact feasibility results: eligible for randomization 69/89 (78%); willing 60/65 (92%); recruitment 3.37/month; training attendance 38/42 (90%); ESWT attendance 60/60 (100%); ≥30/36 training sessions 6/19 (32%). Acceptability baseline: advice 16/20 (80%), training 19/20 (95%), ESWT 20/20 (100%); at 3 months: 11/18 (61%), 13/19 (68%), 20/20 (100%). Understandability baseline: 18/20 (90%), 20/20 (100%), 20/20 (100%); at 3 months: 14/18 (78%), 18/19 (95%), 20/20 (100%). Retention 58/60 (97%) at 3 months and 41/60 (68%) at 6 months. Data completeness: baseline PRTEE, Quick-DASH, EQ-5D-5L and grip 60/60 each; 3 months 57/58, 58/58, 58/58, 58/58; 6 months PRTEE, Quick-DASH and EQ-5D each 41/41. Table 2 has no 6-month grip entry. These process outcomes are descriptive, not efficacy comparisons.

Patient-Rated Tennis Elbow Evaluation total score1 reported outcome
02
Baseline and 3 months

Patient-Rated Tennis Elbow Evaluation total score

Patient-Rated Tennis Elbow Evaluation (PRTEE) PRTEE points

BaselineFollow-up
Radial ESWT
18.1
Heavy-slow resistance training
25.7
Information and advice
23.9
0100 PRTEE points
Patient-Rated Tennis Elbow Evaluation total score · Baseline and 3 months · means
GroupnBaselineFollow-up
Radial ESWT—43.8 (SD 13.9)18.1 (SD 17.5)
Heavy-slow resistance training—43 (SD 19)25.7 (SD 25.2)
Information and advice—48.6 (SD 18.2)23.9 (SD 19.7)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive mean scores decreased in all groups. This feasibility trial was not designed to compare treatment effectiveness.

Analysis details and source

Table 4 baseline and 3-month group means (SD); the 6-month means are separately structured. Arm-specific analyzed n is not stated. Descriptive feasibility data only; not an efficacy comparison.

PRTEE pain subscale2 reported outcomes
03
Baseline and 3 months

PRTEE pain subscale

Patient-Rated Tennis Elbow Evaluation pain PRTEE points (0–50)

BaselineFollow-up
Radial ESWT
11.4
Heavy-slow resistance training
15.9
Information and advice
14.2
050 PRTEE points (0–50)
PRTEE pain subscale · Baseline and 3 months · means
GroupnBaselineFollow-up
Radial ESWT—24.8 (SD 7.6)11.4 (SD 9.6)
Heavy-slow resistance training—24.6 (SD 10.4)15.9 (SD 14.3)
Information and advice—25.2 (SD 9.5)14.2 (SD 10.2)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive group summaries in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Table 4 baseline and 3-month group means (SD); the 6-month means are stored separately in the matching 6-month outcome. Table 4 reports no change scores. Arm-specific n is not supplied for these summary rows; no n has been inferred.

13
6 months

PRTEE pain subscale at 6 months

Patient-Rated Tennis Elbow Evaluation pain PRTEE points (0–50)

BaselineFollow-up
Radial ESWT
9.2
Heavy-slow resistance training
11.9
Information and advice
8.7
050 PRTEE points (0–50)
PRTEE pain subscale at 6 months · 6 months · means
GroupnBaselineFollow-up
Radial ESWT——9.2 (SD 8.8)
Heavy-slow resistance training——11.9 (SD 11.3)
Information and advice——8.7 (SD 5.1)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive 6-month group means (SD) in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Arm-specific analyzed n is not stated in this Table 4 row; no n inferred.

PRTEE function subscale2 reported outcomes
04
Baseline and 3 months

PRTEE function subscale

Patient-Rated Tennis Elbow Evaluation function PRTEE points (0–50)

BaselineFollow-up
Radial ESWT
6.8
Heavy-slow resistance training
9.8
Information and advice
10.3
050 PRTEE points (0–50)
PRTEE function subscale · Baseline and 3 months · means
GroupnBaselineFollow-up
Radial ESWT—19 (SD 7.8)6.8 (SD 8.1)
Heavy-slow resistance training—18.4 (SD 10.1)9.8 (SD 12)
Information and advice—23.4 (SD 9.8)10.3 (SD 10)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive group summaries in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Table 4 baseline and 3-month group means (SD); the 6-month means are stored separately in the matching 6-month outcome. Table 4 reports no change scores. Arm-specific n is not supplied for these summary rows; no n has been inferred.

14
6 months

PRTEE function subscale at 6 months

Patient-Rated Tennis Elbow Evaluation function PRTEE points (0–50)

BaselineFollow-up
Radial ESWT
6.1
Heavy-slow resistance training
8.5
Information and advice
5
050 PRTEE points (0–50)
PRTEE function subscale at 6 months · 6 months · means
GroupnBaselineFollow-up
Radial ESWT——6.1 (SD 7.4)
Heavy-slow resistance training——8.5 (SD 9.1)
Information and advice——5 (SD 3.6)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive 6-month group means (SD) in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Arm-specific analyzed n is not stated in this Table 4 row; no n inferred.

Quick-DASH2 reported outcomes
05
Baseline and 3 months

Quick-DASH

Quick Disabilities of the Arm, Shoulder and Hand points (0–100)

BaselineFollow-up
Radial ESWT
17.5
Heavy-slow resistance training
27.5
Information and advice
26.9
0100 points (0–100)
Quick-DASH · Baseline and 3 months · means
GroupnBaselineFollow-up
Radial ESWT—42 (SD 10.4)17.5 (SD 17.3)
Heavy-slow resistance training—41.1 (SD 18)27.5 (SD 26.7)
Information and advice—46.8 (SD 21.4)26.9 (SD 21.2)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive group summaries in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Table 4 baseline and 3-month group means (SD); the 6-month means are stored separately in the matching 6-month outcome. Table 4 reports no change scores. Arm-specific n is not supplied for these summary rows; no n has been inferred.

16
6 months

Quick-DASH at 6 months

Quick Disabilities of the Arm, Shoulder and Hand points (0–100)

BaselineFollow-up
Radial ESWT
18
Heavy-slow resistance training
24.2
Information and advice
15.7
0100 points (0–100)
Quick-DASH at 6 months · 6 months · means
GroupnBaselineFollow-up
Radial ESWT——18 (SD 15.1)
Heavy-slow resistance training——24.2 (SD 22.2)
Information and advice——15.7 (SD 8.3)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive 6-month group means (SD) in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Arm-specific analyzed n is not stated in this Table 4 row; no n inferred.

EQ-5D-5L index2 reported outcomes
06
Baseline and 3 months

EQ-5D-5L index

EQ-5D-5L index index units (−0.59 to 1)

BaselineFollow-up
Radial ESWT
0.73
Heavy-slow resistance training
0.674
Information and advice
0.761
-0.591 index units (−0.59 to 1)
EQ-5D-5L index · Baseline and 3 months · means
GroupnBaselineFollow-up
Radial ESWT—0.62 (SD 0.136)0.73 (SD 0.269)
Heavy-slow resistance training—0.597 (SD 0.179)0.674 (SD 0.27)
Information and advice—0.551 (SD 0.197)0.761 (SD 0.118)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive group summaries in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Table 4 baseline and 3-month group means (SD); the 6-month means are stored separately in the matching 6-month outcome. Table 4 reports no change scores. Arm-specific n is not supplied for these summary rows; no n has been inferred.

17
6 months

EQ-5D-5L index at 6 months

EQ-5D-5L index index units (−0.59 to 1)

BaselineFollow-up
Radial ESWT
0.771
Heavy-slow resistance training
0.733
Information and advice
0.8
-0.591 index units (−0.59 to 1)
EQ-5D-5L index at 6 months · 6 months · means
GroupnBaselineFollow-up
Radial ESWT——0.771 (SD 0.161)
Heavy-slow resistance training——0.733 (SD 0.232)
Information and advice——0.8 (SD 0.099)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive 6-month group means (SD) in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Arm-specific analyzed n is not stated in this Table 4 row; no n inferred.

Pain-free grip strength1 reported outcome
07
Baseline and 3 months

Pain-free grip strength

Pain-free grip strength kg

BaselineFollow-up
Radial ESWT
31.7
Heavy-slow resistance training
31.9
Information and advice
24.8
0100 kg
Pain-free grip strength · Baseline and 3 months · means
GroupnBaselineFollow-up
Radial ESWT—20.2 (SD 9.4)31.7 (SD 9.7)
Heavy-slow resistance training—23.3 (SD 13.7)31.9 (SD 15.1)
Information and advice—16.6 (SD 8.7)24.8 (SD 10.8)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive group summaries in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Table 4 values are means (SD) for baseline and 3 months. Arm-specific n is not supplied for these summary rows; no n has been inferred.

Pain on gripping1 reported outcome
08
Baseline and 3 months

Pain on gripping

Pain on gripping NRS points (0–10)

BaselineFollow-up
Radial ESWT
0
Heavy-slow resistance training
0
Information and advice
2
010 NRS points (0–10)
Pain on gripping · Baseline and 3 months · medians
GroupnBaselineFollow-up
Radial ESWT—4 (IQR 1–8)0 (IQR 0–4)
Heavy-slow resistance training—5 (IQR 2–8)0 (IQR 0–7)
Information and advice—6 (IQR 4–8)2 (IQR 1–6)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive group summaries in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Table 4 values are medians (IQR) for baseline and 3 months. Arm-specific n is not supplied for these summary rows; no n has been inferred.

Current pain NRS-P1 reported outcome
09
Baseline and 3 months

Current pain NRS-P

Numeric rating scale for pain now NRS points (0–10)

BaselineFollow-up
Radial ESWT
1
Heavy-slow resistance training
2
Information and advice
2
010 NRS points (0–10)
Current pain NRS-P · Baseline and 3 months · medians
GroupnBaselineFollow-up
Radial ESWT—5 (IQR 3–7)1 (IQR 1–4)
Heavy-slow resistance training—5 (IQR 3–7)2 (IQR 0–6)
Information and advice—5 (IQR 2–7)2 (IQR 1–4)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive group summaries in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Table 4 values are medians (IQR) for baseline and 3 months. Arm-specific n is not supplied for these summary rows; no n has been inferred.

GROC success at 3 months3 reported outcomes
10
3 months

GROC success at 3 months

Global Rating of Change (GROC; −6 to +6) participants, n/N (%)

Radial ESWT9 / 20
Heavy-slow resistance training6 / 19
Information and advice3 / 19

Descriptive feasibility-trial responses; categories are reported as printed and are not efficacy contrasts.

Analysis details and source

Table 4 totals: success 18/58 (31%), improved 38/58 (66%), worse 6/58 (10%). Categories as reported may overlap; arm denominators vary.

11
3 months

GROC improved at 3 months

Global Rating of Change (GROC; −6 to +6) participants, n/N (%)

Radial ESWT15 / 20
Heavy-slow resistance training10 / 19
Information and advice13 / 19

Descriptive feasibility-trial responses; categories are reported as printed and are not efficacy contrasts.

Analysis details and source

Table 4 totals: success 18/58 (31%), improved 38/58 (66%), worse 6/58 (10%). Categories as reported may overlap; arm denominators vary.

12
3 months

GROC worse at 3 months

Global Rating of Change (GROC; −6 to +6) participants, n/N (%)

Radial ESWT1 / 20
Heavy-slow resistance training4 / 19
Information and advice1 / 19

Descriptive feasibility-trial responses; categories are reported as printed and are not efficacy contrasts.

Analysis details and source

Table 4 totals: success 18/58 (31%), improved 38/58 (66%), worse 6/58 (10%). Categories as reported may overlap; arm denominators vary.

PRTEE total score at 6 months1 reported outcome
15
6 months

PRTEE total score at 6 months

Patient-Rated Tennis Elbow Evaluation total PRTEE points (0–100)

BaselineFollow-up
Radial ESWT
15.3
Heavy-slow resistance training
20.5
Information and advice
13.7
0100 PRTEE points (0–100)
PRTEE total score at 6 months · 6 months · means
GroupnBaselineFollow-up
Radial ESWT——15.3 (SD 15.9)
Heavy-slow resistance training——20.5 (SD 20.3)
Information and advice——13.7 (SD 8.6)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Descriptive 6-month group means (SD) in a feasibility trial; no comparative effectiveness inference.

Analysis details and source

Arm-specific analyzed n is not stated in this Table 4 row; no n inferred.

How treatment was delivered
Radial shockwave device

EMS-DolorClast with Swiss DolorClast Evo blue handpiece and 15-mm applicator.

Shockwave settings and schedule

Three sessions about one week apart; 2,000 impulses at 10 Hz; low energy 1.5–3 bar; maximal tenderness at lateral epicondyle. No conversion from bar.

Exercise protocol

12 weeks, 36 home sessions, two dumbbell exercises; three sets; 4 s concentric and 4 s eccentric; three times weekly, at least 48 h recovery; load as heavy as possible within repetitions.

Shared advice

All groups received oral and written information, reassurance that pain does not equal harm, and gradual load management advice.

HARMS & TOLERABILITY

Exercise group: five participants reported increased pain from training as an adverse event; eight cited pain aggravation as a reason for non-compliance. ESWT group: two reported increased pain for up to 12 hours. No serious-event summary/count is clearly reported in the inspected source.

LIMITS OF THE ANALYSIS

The authors note that 6-month retention was 68%, below the >75% criterion, and postal questionnaires may explain some loss.

Amber progression cutoffs were not set a priori; authors suggest feasibility success criteria may have been too permissive.

No blinded assessor; acceptability was reported to the treating physiotherapist, risking observer/reporting bias.

Secondary symptoms are descriptive in a feasibility study and should not be treated as efficacy comparisons.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • The authors note that 6-month retention was 68%, below the >75% criterion, and postal questionnaires may explain some loss.
  • Amber progression cutoffs were not set a priori; authors suggest feasibility success criteria may have been too permissive.
  • No blinded assessor; acceptability was reported to the treating physiotherapist, risking observer/reporting bias.
  • Secondary symptoms are descriptive in a feasibility study and should not be treated as efficacy comparisons.
Research review

Source-linked critical reading

Randomized feasibility trial

Reading depthMaterial consulted
Technical source record

All article sections, Tables 1–4 and footnotes, figure captions, Results, Discussion, limitations and disclosure/data statements read. Raw XML contains four table-wraps matching parsed tables. Reviewer comments PDF referenced by the source was unavailable.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design

Single-centre, three-arm, 1:1:1 randomized feasibility trial with follow-up at 3 and 6 months. A feasibility study, not an effectiveness trial; symptom outcomes are descriptive.

Participants

60 adults with tennis elbow were randomized, 20 per group. Mean age was 47.8 years (SD 9.3); 68% were women and 90% had symptoms for over three months.

Interventions

Radial ESWT used EMS-DolorClast Evo blue handpiece, 15-mm applicator, three sessions about one week apart, 2,000 impulses at 10 Hz and 1.5–3 bar, focused on maximal lateral-epicondyle tenderness. Heavy-slow resistance group received a 12-week home program of 36 sessions, wrist flexion/extension and forearm pronation/supination with dumbbell, three sets, 4-s concentric/4-s eccentric, three times weekly; load was as heavy as possible for prescribed reps. All groups received written/oral information and advice; the advice-only group had one individual session up to 45 minutes.

Comparator

Information and advice alone was the comparison group. The trial was designed to test recruitment, adherence, acceptability, retention and data completeness; it was not powered or designed for treatment-effect comparisons. The advice-only group could cross over after the 3-month follow-up.

Outcomes

Feasibility endpoints included recruitment, appointment attendance, intervention compliance, acceptability/comprehensibility, retention and data completeness. Secondary outcomes included PRTEE, Quick-DASH, EQ-5D-5L, pain-free grip strength, pain on gripping, NRS pain now and global rating of change. Outcomes were collected at baseline, 3 months and (questionnaires) 6 months.

Symptom outcomes

Recruitment was 3.37 participants/month; 69/89 screened patients (78%) were eligible and 60/65 eligible patients (92%) accepted randomization. ESWT attendance was 60/60 sessions (100%); training participants completed median 26 of 36 sessions (range 6–35), with 6/19 (32%) reaching ≥30 sessions. Retention was 58/60 (97%) at 3 months and 41/60 (68%) at 6 months, below the prespecified >75% threshold. At 3 months median NRS pain-now was 1 (IQR 1–4) ESWT, 2 (0–6) training and 2 (1–4) advice; PRTEE total mean scores were 18.1, 25.7 and 23.9, respectively. Authors caution these are descriptive feasibility data, not comparative efficacy results.

Harms

Five exercise-group participants reported increased pain during training as an adverse event; eight reported increased pain as a reason for non-compliance. Two ESWT participants reported increased pain lasting up to 12 hours. No serious event count is stated in the inspected report.

Limitations

The authors note 6-month retention was low, the traffic-light amber cut-off was not prespecified, the exercise group had no mandatory supervision, there was no blinded assessor, and acceptability was reported directly to the treating physiotherapist. Health-economic questionnaire feasibility was not assessed. Patients recently treated with shockwave/exercise/other treatments were not excluded, which may influence symptom descriptions.

Applicability

The study indicates ESWT sessions and recruitment were feasible, while 6-month retention and adherence to heavy-slow exercise need changes. As a feasibility trial, descriptive improvement in symptoms cannot establish ESWT benefit over advice or exercise.

Next trial

The authors recommend a full-scale randomized trial of radial ESWT and information/advice including sham ESWT. It should address retention, supervision, adverse-event monitoring, participant blinding and health economics.

THE ORIGINAL SOURCE

Read the original article.

Heavy slow resistance training, radial extracorporeal shock wave therapy or advice for patients with tennis elbow in the Norwegian secondary care: a randomised controlled feasibility trial.

Sveinall H, Brox JI, Engebretsen KB, Hoksrud AF, Røe C, Johnsen MB. · BMJ open · 2024

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →